PALDRONABOL

Serial Number 97724128
602

Registration Progress

Application Filed
Dec 19, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

PALDRONABOL

Basic Information

Serial Number
97724128
Filing Date
December 19, 2022
Abandonment Date
August 31, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 13, 2023
Classes
042

Rights Holder

Prepaire IP Development

03
Address
P.O. Box 448, Elgin Court, Elgin Avenue
George Town KY1-1106
KY

Ownership History

Prepaire IP Development

Original Applicant
03
George Town KY

Legal Representation

Attorney
Michael G Shariff

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Sep 13, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 13, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Sep 13, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Drug discovery services for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Pharmaceutical research services; Research on the subject of pharmaceuticals for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics for alleviating the symptoms of Parkinsonism/ Parkinson's disease ; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations and medicines for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation, scientific and technological services and research and design services relating thereto, namely, scientific research, research and design in the fields of pharmaceuticals, agrochemicals, bioactive compounds, fine chemicals, chemical feed stocks, polymers, paints, dyestuffs, adhesives, material sciences, engineering, nanomaterials, and foodstuffs; Chemical research; Chemical research, namely, chemical technological research; Chemical analysis; Chemistry services, namely, chemistry research, laboratory research in the field of chemistry; Chemistry consultation; Scientific research relating to chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Research and development services in the field of chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Design and development of chemical compounds; Design and development of synthetic chemical compounds; Rental of laboratory apparatus and instruments for alleviating the symptoms of Parkinsonism/ Parkinson's disease
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042